E Fund Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
48,865
+10,920
| +29% | +$301K | 0.06% | 138 |
|
|
2025
Q1 | $1.08M | Buy |
37,945
+7,353
| +24% | +$208K | 0.05% | 161 |
|
|
2024
Q4 | $1.27M | Buy |
30,592
+7,939
| +35% | +$330K | 0.06% | 134 |
|
|
2024
Q3 | $1.51M | Buy |
22,653
+9,616
| +74% | +$643K | 0.08% | 105 |
|
|
2024
Q2 | $1.55M | Buy |
13,037
+2,343
| +22% | +$278K | 0.09% | 96 |
|
|
2024
Q1 | $1.14M | Sell |
10,694
-1,604
| -13% | -$171K | 0.07% | 105 |
|
|
2023
Q4 | $1.22M | Buy |
12,298
+3,121
| +34% | +$310K | 0.08% | 80 |
|
|
2023
Q3 | $948K | Buy |
9,177
+1,396
| +18% | +$144K | 0.07% | 85 |
|
|
2023
Q2 | $945K | Buy |
7,781
+235
| +3% | +$28.5K | 0.07% | 76 |
|
|
2023
Q1 | $1.16M | Buy |
7,546
+268
| +4% | +$41.2K | 0.08% | 75 |
|
|
2022
Q4 | $1.31M | Sell |
7,278
-1,662
| -19% | -$298K | 0.11% | 73 |
|
|
2022
Q3 | $1.06M | Buy |
8,940
+237
| +3% | +$28K | 0.1% | 86 |
|
|
2022
Q2 | $1.24M | Buy |
8,703
+1,503
| +21% | +$215K | 0.11% | 78 |
|
|
2022
Q1 | $1.24M | Buy |
7,200
+1,477
| +26% | +$254K | 0.04% | 76 |
|
|
2021
Q4 | $1.45M | Buy |
5,723
+519
| +10% | +$132K | 0.05% | 86 |
|
|
2021
Q3 | $2M | Buy |
+5,204
| New | +$2M | 0.08% | 65 |
|
|
2021
Q1 | $661K | Buy |
+5,046
| New | +$661K | 0.05% | 113 |
|